Anticoagulants' high demand is predicted to grow the market as a whole. Additionally, rising health care costs and government-sponsored programmes are some of the main drivers projected to fuel market expansion. One of the main factors influencing the overall Heparin Market is thought to be the rising prevalence of chronic diseases such cardiovascular disorders, deep vein thrombosis, pulmonary embolism, and renal diseases.
Heparin, sometimes referred to as unfractionated heparin (UFH), is a naturally occurring glycosaminoglycan. In medicine, it serves as an anticoagulant (blood thinner). Treatment of unstable angina and heart attacks benefits greatly from it. It is injected into a vein or subcutaneously.
Acute coronary syndrome, deep vein thrombosis, pulmonary embolism, atrial fibrillation, cardiopulmonary bypass, and hemofiltration are just a few of the conditions it is used to treat. The administration of major orthopaedic surgeries like hip and knee replacements also makes use of it.
